Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-01-04 11:29 am Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | Broadfin Capital LLC | 0 0.000% | -1,236,368 (Position Closed) | View |
2021-01-04 11:15 am Sale | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | Broadfin Capital LLC | 0 0.000% | -2,688,068 (Position Closed) | View |
2020-06-23 5:27 pm Sale | 13D | STRATA Skin Sciences Inc. SSKN | Broadfin Capital LLC | 1,529,392 4.540% | -641,365 (-29.55%) | View |
2020-02-24 7:21 pm Unchanged | 13G | Teligent Inc. TLGT | Broadfin Capital LLC | 0 0.000% | 0 (Unchanged) | View |
2020-02-13 5:34 pm Sale | 13G | NEOS THERAPEUTICS INC NEOS | Broadfin Capital LLC | 0 0.000% | -2,618,819 (Position Closed) | View |
2020-02-13 5:28 pm Unchanged | 13G | Zyla Life Sciences ZCOR | Broadfin Capital LLC | 0 0.000% | 0 (Unchanged) | View |
2020-02-13 5:27 pm Sale | 13G | ADMA BIOLOGICS INC ADMA | Broadfin Capital LLC | 0 0.000% | -4,226,077 (Position Closed) | View |
2020-02-13 5:26 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC AVDL | Broadfin Capital LLC | 1,029,012 2.750% | -2,073,661 (-66.83%) | View |
2020-02-13 5:24 pm Purchase | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | Broadfin Capital LLC | 2,688,068 9.900% | 740,527 (+38.02%) | View |
2020-02-13 5:22 pm Unchanged | 13G | Sierra Oncology Inc. SRRA | Broadfin Capital LLC | 0 0.000% | 0 (Unchanged) | View |
2020-02-13 5:21 pm Sale | 13G | TELIGENT INC TLGT | Broadfin Capital LLC | 0 0.000% | -2,823,383 (Position Closed) | View |
2020-02-13 5:20 pm Sale | 13G | Strongbridge Biopharma plc SBBP | Broadfin Capital LLC | 600,000 1.090% | -2,221,722 (-78.74%) | View |
2020-02-13 5:19 pm Unchanged | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Broadfin Capital LLC | 0 0.000% | 0 (Unchanged) | View |
2020-02-13 5:19 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | Broadfin Capital LLC | 1,888,039 4.560% | -392,221 (-17.20%) | View |
2020-02-13 5:18 pm Sale | 13G | Adamas Pharmaceuticals Inc ADMS | Broadfin Capital LLC | 0 0.000% | -2,614,468 (Position Closed) | View |
2020-02-13 5:16 pm Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | Broadfin Capital LLC | 1,236,368 5.050% | -419,769 (-25.35%) | View |
2020-02-13 5:13 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | Broadfin Capital LLC | 0 0.000% | -2,077,432 (Position Closed) | View |
2020-02-13 5:12 pm Sale | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Broadfin Capital LLC | 0 0.000% | -6,268,298 (Position Closed) | View |
2020-02-13 5:09 pm Sale | 13G | Societal CDMO Inc. SCTL | Broadfin Capital LLC | 721,073 3.170% | -1,326,952 (-64.79%) | View |
2020-01-22 5:59 pm Unchanged | 13D | STRATA Skin Sciences Inc. SSKN | Broadfin Capital LLC | 2,170,757 6.390% | 0 (Unchanged) | View |